Pharmaceutical Regulatory Affairs: Open Access

Ramirez-Torres Nicolas MC

Publications

• Review Article
  Cost-Effectiveness Analysis of Neoadjuvant Chemotherapy with Intensive Dose of Epirubicin and Different Cycles in Patients with Locally Advanced Breast Cancer: 4 Fe₁₀₀c Vs. 6 Fe₁₀₀ C
  Author(s): Ramirez-Torres Nicolas MC, Herrera-Abarca Jorge Eduardo DC, Chavez-Carbajal Jose Fortino MC and Hernandez Valencia Marcelino DCRamirez-Torres Nicolas MC, Herrera-Abarca Jorge Eduardo DC, Chavez-Carbajal Jose Fortino MC and Hernandez Valencia Marcelino DC
  
  Introduction: There are different combinations of neoadjuvant chemotherapy (NCT) to treat locally advanced breast cancer (LABC); treatment with cytostatics drugs make it a costly concern, by establishing economic differences in the consumption of health care resources. Objective: To compare the cost-effectiveness of two NCT strategies. Patients and method: it was made a cost-effectiveness analysis (CEA) of two treatment schemes (4FE100C vs.6FE100C) in patients with clinical stage III breast cancer, each cohort included 48 pati.. Read More»
  DOI: 10.4172/2167-7689.1000113

  Abstract PDF